While HIV treatment has come a long way over the decades, it still faces challenges. Specifically, HIV therapy such as integrase inhibitors have been associated with increased weight gain but the mechanism and extent of which has remained largely unknown. Listen in as Dave Hachey, HIV expert, and Geoff Wall discuss this and how it impacts medication selection when caring for patients with HIV.
00:00 – Introductions
04:36 – HIV Treatment & Weight Gain
07:27 – Integrase Inhibitors vs Tenofovir Alafenamide
17:12 – The GameChanger
26:22 – Closing Remarks
David Hachey, PharmD, AAHIVP Professor Idaho State University
After graduating from the University of Rhode Island, Dr. Hachey completed a residency and fellowship in Family Medicine at Idaho State University. After, he stayed in Idaho and expanded his role with the College of Pharmacy and the Department of Family Medicine. Dr. Hachey has experience within the community setting and has also served as the director of the regional Ryan White HIV Clinic for the last 15-20 years. His vast experience gives him a unique perspective on the challenges pharmacists and patients face in preventing and managing HIV.
Links to Resources:
How to Claim CE:
CE is available for CEimpact members.
Get a membership:
References and resources:
Continuing Education Information:
Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Hachey reports no actual or potential conflicts of interest associated with this episode.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-070-H01-P
Initial release date: 01/03/22
Expiration date: 01/03/2023
Additional CPE & CME details can be found here